Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis Type II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01553149
What this trial is testing

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

Who this might be right for
Neurofibromatosis Type 1Recurrent Childhood Pilocytic AstrocytomaRecurrent Childhood Visual Pathway Glioma
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT03210285
What this trial is testing

WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaAcoustic Neuroma
University Hospital Tuebingen 70
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT01089101
What this trial is testing

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Low Grade GliomaRecurrent Childhood Pilocytic AstrocytomaRecurrent Neurofibromatosis Type 1+3 more
National Cancer Institute (NCI) 217
Not applicableStudy completedNCT01222728
What this trial is testing

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Who this might be right for
NeoplasmsNervous System DiseaseVestibular Disease
National Institute of Neurological Disorders and Stroke (NINDS) 5
Post-approval studies (Phase 4)WithdrawnNCT00588172
What this trial is testing

Genetic Variation in OCT1 and Response to Metformin

Who this might be right for
Type 2 Diabetes
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT02124772
What this trial is testing

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Who this might be right for
Cancer
Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Study completedNCT01024946
What this trial is testing

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center 11
Early research (Phase 1)WithdrawnNCT01850225
What this trial is testing

Feasibility Study of Auditory Brainstem Implant in Young Children

Who this might be right for
Bilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis
House Research Institute
Not applicableEnded earlyNCT01864291
What this trial is testing

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 9
Not applicableNot Yet RecruitingNCT07818213
What this trial is testing

How Can the Experience of Hospital Outpatient Departments be Improved?

Who this might be right for
Neurofibromatosis Type 1 (NF1)NF2-related Schwannomatosis
King's College London 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621082
What this trial is testing

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

Who this might be right for
Neurofibromatosis 1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 19
Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableUnknownNCT00004483
What this trial is testing

NF2 Natural History Consortium

Who this might be right for
Schwannoma, VestibularNeurofibromatosis 2Meningioma
House Ear Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT04750928
What this trial is testing

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01412892
What this trial is testing

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaNeurofibromatoses
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439318
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Ended earlyNCT02256124
What this trial is testing

Effect of Lamotrigine on Cognition in NF1

Who this might be right for
Neurofibromatosis Type 1
Erasmus Medical Center 41
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)Study completedNCT00853580
What this trial is testing

Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
University of Alabama at Birmingham 146
Next Page